| Primary |
| Acne |
17.6% |
| Lyme Disease |
10.1% |
| Pneumonia |
8.8% |
| Hypertension |
7.2% |
| Lower Respiratory Tract Infection |
6.0% |
| Infection |
5.3% |
| Rosacea |
5.3% |
| Sinusitis |
4.7% |
| Product Used For Unknown Indication |
3.8% |
| Cardiac Failure |
3.5% |
| Malaria Prophylaxis |
3.5% |
| Prophylaxis |
3.5% |
| Bronchitis |
3.1% |
| Pain |
3.1% |
| Drug Use For Unknown Indication |
2.8% |
| Urinary Tract Infection |
2.8% |
| Central Nervous System Lymphoma |
2.5% |
| Cough |
2.2% |
| Respiratory Tract Infection |
2.2% |
| Anxiety |
1.9% |
|
| Drug Hypersensitivity |
26.3% |
| Vomiting |
7.8% |
| Stevens-johnson Syndrome |
6.0% |
| Drug Ineffective |
5.5% |
| Rash |
5.5% |
| Nausea |
4.6% |
| Hypersensitivity |
4.1% |
| Vision Blurred |
4.1% |
| Oesophagitis |
3.7% |
| Pain |
3.7% |
| Palpitations |
3.7% |
| Pruritus |
3.7% |
| Urticaria |
3.2% |
| Arthralgia |
2.8% |
| Burn Oesophageal |
2.8% |
| No Adverse Event |
2.8% |
| Oesophageal Ulcer |
2.8% |
| Drug Interaction |
2.3% |
| Pancreatitis |
2.3% |
| Pyrexia |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
41.1% |
| Hypertension |
7.4% |
| Depression |
4.2% |
| Acne |
4.0% |
| Infection |
4.0% |
| Neuralgia |
3.8% |
| Pain |
3.8% |
| Lyme Disease |
3.4% |
| Cardiac Failure |
3.2% |
| Drug Use For Unknown Indication |
3.0% |
| Mycobacterium Avium Complex Infection |
3.0% |
| Tooth Abscess |
2.5% |
| Anxiety |
2.1% |
| Atrial Fibrillation |
2.1% |
| Diabetes Mellitus |
2.1% |
| Lower Respiratory Tract Infection |
2.1% |
| Pulmonary Embolism |
2.1% |
| Urinary Tract Infection |
2.1% |
| Non-small Cell Lung Cancer Nos |
1.9% |
| Respiratory Tract Irritation |
1.9% |
|
| Drug Hypersensitivity |
35.4% |
| Liver Function Test Abnormal |
7.1% |
| Malaise |
4.0% |
| Mobility Decreased |
4.0% |
| Ocular Icterus |
4.0% |
| Rash |
4.0% |
| Vomiting |
4.0% |
| Acquired Haemophilia |
3.0% |
| Drug Ineffective |
3.0% |
| Gallbladder Disorder |
3.0% |
| Gastrooesophageal Reflux Disease |
3.0% |
| International Normalised Ratio Increased |
3.0% |
| Myositis |
3.0% |
| Rash Maculo-papular |
3.0% |
| Stevens-johnson Syndrome |
3.0% |
| Toxic Epidermal Necrolysis |
3.0% |
| Urticaria |
3.0% |
| Weight Decreased |
3.0% |
| Asthenia |
2.0% |
| Haematemesis |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.8% |
| Drug Use For Unknown Indication |
18.4% |
| Pain |
8.3% |
| Acne |
3.5% |
| Contraception |
2.7% |
| Anxiety |
2.6% |
| Hypertension |
2.5% |
| Non-small Cell Lung Cancer |
2.5% |
| Asthma |
2.3% |
| Nausea |
2.3% |
| Depression |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Constipation |
1.8% |
| Multiple Myeloma |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
| Back Pain |
1.4% |
| Endophthalmitis |
1.4% |
| Headache |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Fatigue |
1.2% |
|
| Pain |
11.7% |
| Vomiting |
10.5% |
| Pulmonary Embolism |
7.4% |
| Weight Decreased |
6.8% |
| Wound Drainage |
6.8% |
| Hyponatraemia |
5.6% |
| Death |
4.9% |
| Pneumonia Aspiration |
4.9% |
| Pulmonary Infarction |
4.9% |
| Vision Blurred |
4.3% |
| Weight Increased |
4.3% |
| Miosis |
3.7% |
| Deep Vein Thrombosis |
3.1% |
| Dyspnoea |
3.1% |
| Oedema Peripheral |
3.1% |
| Platelet Count Decreased |
3.1% |
| Pneumonia |
3.1% |
| Ulcer |
3.1% |
| Wheezing |
3.1% |
| Abdominal Pain |
2.5% |
|
| Interacting |
| Diabetes Mellitus |
18.8% |
| Arthralgia |
15.6% |
| Atrial Fibrillation |
9.4% |
| Blood Pressure Abnormal |
9.4% |
| Localised Infection |
9.4% |
| Human Ehrlichiosis |
6.3% |
| Upper Respiratory Tract Infection |
6.3% |
| Anxiety |
3.1% |
| Complex Partial Seizures |
3.1% |
| Hypertension |
3.1% |
| Oedema |
3.1% |
| Partial Seizures |
3.1% |
| Phytotherapy |
3.1% |
| Pneumonia |
3.1% |
| Respiratory Tract Infection |
3.1% |
|
| Atrial Fibrillation |
18.2% |
| Drug Interaction |
18.2% |
| Sudden Death |
18.2% |
| Drug Ineffective |
9.1% |
| Hyponatraemia |
9.1% |
| Petit Mal Epilepsy |
9.1% |
| Upper Respiratory Tract Infection |
9.1% |
| Ventricular Tachycardia |
9.1% |
|
